Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to WASATCH MOLECULAR, INC. in August, 2018 for $750,000.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8651-18-C-0061 | Phase II | 750,000 | August 16, 2018 | |||||||
A SBIR Phase II contract was awarded to WASATCH MOLECULAR, INC. in March, 2020 for $745,214.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA9300-20-C-2007 | Phase II | 745,214 | March 23, 2020 | |||||||
A STTR Phase II contract was awarded to WASATCH MOLECULAR, INC. in December, 2008 for $750,000.0 USD from the U.S. Department of Defense. | STTR | FA9550-09-C-0110 | Phase II | 750,000 | December 2, 2008 | |||||||
A STTR Phase I contract was awarded to WASATCH MOLECULAR, INC. in October, 2007 for $99,926.0 USD from the U.S. Department of Defense. | STTR | FA9550-08-C-0003 | Phase I | 99,926 | October 26, 2007 | |||||||
A STTR Phase I contract was awarded to WASATCH MOLECULAR, INC. in September, 2015 for $150,000.0 USD from the U.S. Department of Defense. | STTR | FA8651-15-M-0298 | Phase I | 150,000 | September 30, 2015 | |||||||
A STTR Phase II contract was awarded to WASATCH MOLECULAR, INC. in August, 2017 for $749,977.0 USD from the U.S. Department of Defense. | STTR | FA8651-17-C-0076 | Phase II | 749,977 | August 31, 2017 | |||||||
A STTR Phase I contract was awarded to WASATCH MOLECULAR, INC. in February, 2019 for $149,005.0 USD from the U.S. Department of Energy. | STTR | DE-SC0019694 | Phase I | 149,005 | February 19, 2019 | |||||||
A SBIR Phase II contract was awarded to WASATCH MOLECULAR, INC. in July, 2010 for $746,705.0 USD from the U.S. Department of Defense. | SBIR | FA8651-10-C-0151 | Phase II | 746,705 | July 1, 2010 | |||||||
A SBIR Phase I contract was awarded to WASATCH MOLECULAR, INC. in July, 2009 for $99,998.0 USD from the U.S. Department of Defense. | SBIR | FA8650-09-M-2036 | Phase I | 99,998 | July 17, 2009 | |||||||
A SBIR Phase I contract was awarded to WASATCH MOLECULAR, INC. in August, 2017 for $149,999.0 USD from the U.S. Department of Defense. | SBIR | FA8651-17-P-0102 | Phase I | 149,999 | August 16, 2017 | |||||||
A STTR Phase I contract was awarded to WASATCH MOLECULAR, INC. in September, 2016 for $149,999.0 USD from the U.S. Department of Defense. | STTR | FA8651-16-P-0245 | Phase I | 149,999 | September 26, 2016 | |||||||
A SBIR Phase I contract was awarded to WASATCH MOLECULAR, INC. in October, 2012 for $80,000.0 USD from the U.S. Department of Defense. | SBIR | N00014-13-M-0018 | Phase I | 80,000 | October 25, 2012 | |||||||
A SBIR Phase I contract was awarded to WASATCH MOLECULAR, INC. in May, 2008 for $99,938.0 USD from the U.S. Department of Defense. | SBIR | FA8651-08-M-0125 | Phase I | 99,938 | May 21, 2008 | |||||||
A SBIR Phase II contract was awarded to WASATCH MOLECULAR, INC. in June, 2011 for $749,926.0 USD from the U.S. Department of Defense. | SBIR | FA9300-11-C-3012 | Phase II | 749,926 | June 2, 2011 | |||||||
A SBIR Phase I contract was awarded to WASATCH MOLECULAR, INC. in January, 2013 for $150,000.0 USD from the National Science Foundation. | SBIR | 1248160 | Phase I | 150,000 | January 1, 2013 |